Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.
Burstein
R
R
Jakubowski
M
M
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D004008:Diclofenac / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D015999:Multivariate Analysis; D010812:Physical Stimulation; D010865:Pilot Projects; D015995:Prevalence; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage*; D020886:Somatosensory Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D016896:Treatment Outcome; D014363:Tryptamines / Q000008:administration & dosage* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D004008:Diclofenac; C409045:almotriptan; C056498:aceclofenac